Welcome! If you have a coupon code, click here to apply it. Apply
stock
Abbott Laboratories
NYSE | ABT
129.50
USD
0.00 ( 0.00%)
AT CLOSE (AS OF Apr 30, 2025)
$226B
MARKET CAP
16.95
P/E Ratio
7.64
EPS
$141
52 Week High
$98
52 Week Low
LIFE SCIENCES
Sector
ABT Chart
1D
Area
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
ABT Technicals
ABT Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $23B |
| Total Revenue | $42B |
| Cost Of Revenue | $19B |
| Costof Goods And Services Sold | $19B |
| Operating Income | $6.8B |
| Selling General And Administrative | $12B |
| Research And Development | $2.8B |
| Operating Expenses | $16B |
| Investment Income Net | - |
| Net Interest Income | -$215M |
| Interest Income | $344M |
| Interest Expense | $559M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.2B |
| Income Before Tax | $7B |
| Income Tax Expense | -$6.4B |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $13B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $7.6B |
| Ebitda | $11B |
| Net Income | $13B |
Revenue & Profitability
Earnings Performance
ABT Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $81B |
| Total Current Assets | $24B |
| Cash And Cash Equivalents At Carrying Value | $7.6B |
| Cash And Short Term Investments | $7.6B |
| Inventory | $6.2B |
| Current Net Receivables | $9.5B |
| Total Non Current Assets | $58B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $6.6B |
| Intangible Assets Excluding Goodwill | $6.6B |
| Goodwill | $23B |
| Investments | - |
| Long Term Investments | $886M |
| Short Term Investments | $351M |
| Other Current Assets | - |
| Other Non Current Assets | - |
| Total Liabilities | $34B |
| Total Current Liabilities | $14B |
| Current Accounts Payable | $4.2B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.5B |
| Total Non Current Liabilities | $19B |
| Capital Lease Obligations | $896M |
| Long Term Debt | $13B |
| Current Long Term Debt | $1.5B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $15B |
| Other Current Liabilities | $7.9B |
| Other Non Current Liabilities | $3.4B |
| Total Shareholder Equity | $48B |
| Treasury Stock | - |
| Retained Earnings | $47B |
| Common Stock | $25B |
| Common Stock Shares Outstanding | $1.7B |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $8.6B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $3.2B |
| Capital Expenditures | $2.2B |
| Change In Receivables | - |
| Change In Inventory | -$58M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | -$5.4B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $3.8B |
| Dividend Payout Common Stock | $3.8B |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$1.3B |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $13B |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $23B |
| Total Revenue | $42B |
| Cost Of Revenue | $19B |
| Costof Goods And Services Sold | $19B |
| Operating Income | $6.8B |
| Selling General And Administrative | $12B |
| Research And Development | $2.8B |
| Operating Expenses | $16B |
| Investment Income Net | - |
| Net Interest Income | -$215M |
| Interest Income | $344M |
| Interest Expense | $559M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.2B |
| Income Before Tax | $7B |
| Income Tax Expense | -$6.4B |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $13B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $7.6B |
| Ebitda | $11B |
| Net Income | $13B |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-04-15 |
| Declaration Date | 2025-02-21 |
| Record Date | 2025-04-15 |
| Payment Date | 2025-05-15 |
| Amount | 0.59 |
ABT News
ABT Profile
Abbott Laboratories Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
DMN 97.37%
$0.0075
LGMK 10.43%
$0.018
PTPI -8.46%
$0.0119
WW 77.03%
$0.732
GNLN -8.66%
$0.0116
NVNI 73.66%
$0.3699
NVDA 0.27%
$109.02
PLUG -10.13%
$0.862
AMCR -3.12%
$9.33
SNAP -14.10%
$7.808
TSLA -3.92%
$280.59
LCID -3.71%
$2.465
F -2.27%
$9.92
JFBR 62.35%
$1.38
PLTR 1.77%
$118.1352
SMCI -14.32%
$30.845
SOFI -6.86%
$12.36
AGMH 2.05%
$0.1045
AAL 0.51%
$9.9
LYT -16.78%
$0.0982
DNN -0.70%
$1.41
GCTK 9.98%
$0.1885
INTC -1.86%
$19.9623
BTE -3.85%
$1.5384
DGLY -6.10%
$0.0354
BTG 0.32%
$3.1099
JBLU 4.90%
$4.385
ABEV 0.20%
$2.545
MARA 1.50%
$14.22
RIG -2.50%
$2.145
LYG -1.38%
$3.925
PFE 2.02%
$24.2698
RIVN 1.17%
$13.455
SBUX -6.27%
$79.531
HIMS -5.93%
$32.9618
BBD 0.21%
$2.435
EJH -47.46%
$0.4099
GRAB 1.77%
$4.875
APLD -1.12%
$4.43
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
NGD 17.16%
$3.925
AMZN -2.90%
$181.9588
VRN -3.61%
$5.87
HOOD -3.32%
$47.73
LUV 2.29%
$27.26
FRGT 21.14%
$1.2109
RIOT -2.90%
$7.205
RGLS 135.02%
$7.9201
STEM 28.27%
$0.5323
NCLH -8.25%
$15.9454
CCL -2.97%
$18.155
WBD -2.70%
$8.5329
TLRY 0.04%
$0.49
VALE -3.18%
$9.295
NIO -4.69%
$4.0412
AAPL -0.49%
$210.1789
AGNC -3.31%
$8.77
ACHR 5.39%
$8.99
BAC -1.38%
$39.4399
AMD -0.34%
$96.06
WULF -4.67%
$2.7835
ERIC -1.33%
$8.19
VOD 1.78%
$9.7501
FNA 0.00%
$13.09
STSS 10.00%
$5.5
BERY -2.93%
$67.58
ITUB -0.63%
$6.2705
GOOGL -1.74%
$157.37
HTZ -13.63%
$7.35
BON -9.52%
$0.0656
QBTS -2.50%
$6.825
HL -1.99%
$5.6847
T 0.77%
$27.51
ABEO 25.38%
$6.645
OCEA 15.15%
$0.0076
VZ 2.27%
$43.925
AZUL -4.92%
$0.7987
PBR -1.91%
$11.3
FFAI -5.18%
$1.2326
MU -0.81%
$76.26
IQ -2.39%
$1.835
CGC -0.72%
$1.38
FSM 2.39%
$6.215
ET -3.31%
$16.476
HLN 0.49%
$10.28
BCS 1.00%
$16.13
KGC 0.17%
$14.615
CLSK -3.85%
$8.115
MSFT -1.04%
$389.9588
PCG -5.39%
$16.415
META -2.51%
$540.5
PTEN -5.80%
$5.605
SOUN -2.64%
$9.2199
AG -0.48%
$6.2201
LITM -25.61%
$0.3241
KHC 0.21%
$28.87
CEP 30.36%
$42.68
RXRX -3.06%
$5.545
CX 0.29%
$6.1076
DMN 97.37%
$0.0075
LGMK 10.43%
$0.018
PTPI -8.46%
$0.0119
WW 77.03%
$0.732
GNLN -8.66%
$0.0116
NVNI 73.66%
$0.3699
NVDA 0.27%
$109.02
PLUG -10.13%
$0.862
AMCR -3.12%
$9.33
SNAP -14.10%
$7.808
TSLA -3.92%
$280.59
LCID -3.71%
$2.465
F -2.27%
$9.92
JFBR 62.35%
$1.38
PLTR 1.77%
$118.1352
SMCI -14.32%
$30.845
SOFI -6.86%
$12.36
AGMH 2.05%
$0.1045
AAL 0.51%
$9.9
LYT -16.78%
$0.0982
DNN -0.70%
$1.41
GCTK 9.98%
$0.1885
INTC -1.86%
$19.9623
BTE -3.85%
$1.5384
DGLY -6.10%
$0.0354
BTG 0.32%
$3.1099
JBLU 4.90%
$4.385
ABEV 0.20%
$2.545
MARA 1.50%
$14.22
RIG -2.50%
$2.145
LYG -1.38%
$3.925
PFE 2.02%
$24.2698
RIVN 1.17%
$13.455
SBUX -6.27%
$79.531
HIMS -5.93%
$32.9618
BBD 0.21%
$2.435
EJH -47.46%
$0.4099
GRAB 1.77%
$4.875
APLD -1.12%
$4.43
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
NGD 17.16%
$3.925
AMZN -2.90%
$181.9588
VRN -3.61%
$5.87
HOOD -3.32%
$47.73
LUV 2.29%
$27.26
FRGT 21.14%
$1.2109
RIOT -2.90%
$7.205
RGLS 135.02%
$7.9201
STEM 28.27%
$0.5323
NCLH -8.25%
$15.9454
CCL -2.97%
$18.155
WBD -2.70%
$8.5329
TLRY 0.04%
$0.49
VALE -3.18%
$9.295
NIO -4.69%
$4.0412
AAPL -0.49%
$210.1789
AGNC -3.31%
$8.77
ACHR 5.39%
$8.99
BAC -1.38%
$39.4399
AMD -0.34%
$96.06
WULF -4.67%
$2.7835
ERIC -1.33%
$8.19
VOD 1.78%
$9.7501
FNA 0.00%
$13.09
STSS 10.00%
$5.5
BERY -2.93%
$67.58
ITUB -0.63%
$6.2705
GOOGL -1.74%
$157.37
HTZ -13.63%
$7.35
BON -9.52%
$0.0656
QBTS -2.50%
$6.825
HL -1.99%
$5.6847
T 0.77%
$27.51
ABEO 25.38%
$6.645
OCEA 15.15%
$0.0076
VZ 2.27%
$43.925
AZUL -4.92%
$0.7987
PBR -1.91%
$11.3
FFAI -5.18%
$1.2326
MU -0.81%
$76.26
IQ -2.39%
$1.835
CGC -0.72%
$1.38
FSM 2.39%
$6.215
ET -3.31%
$16.476
HLN 0.49%
$10.28
BCS 1.00%
$16.13
KGC 0.17%
$14.615
CLSK -3.85%
$8.115
MSFT -1.04%
$389.9588
PCG -5.39%
$16.415
META -2.51%
$540.5
PTEN -5.80%
$5.605
SOUN -2.64%
$9.2199
AG -0.48%
$6.2201
LITM -25.61%
$0.3241
KHC 0.21%
$28.87
CEP 30.36%
$42.68
RXRX -3.06%
$5.545
CX 0.29%
$6.1076
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.